Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Ovarian Neoplasms × Drugs, Generic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Keratosis, Actinic 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 77 Carboplatin 63 Bevacizumab 31 liposomal doxorubicin 28 Topotecan 27 Gemcitabine 23 Cisplatin 19 olaparib 18 Drug Therapy 12 Doxorubicin 12 Taxes 11 niraparib 9 Docetaxel 6 CP protocol 6 Trabectedin 5 Hyperthermic Intraperitoneal Chemotherapy 5 Etoposide 5 Cyclophosphamide 5 rucaparib 4 avelumab 4 atezolizumab 4 Immunoglobulin G 4 Ifosfamide 4 Disulfides 4 Dexamethasone 4 Chemotherapy, Adjuvant 4 1-dodecylpyridoxal 4 trebananib 3 pembrolizumab 3 fluzoparib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00189553 2014-01-10

CALYPSO

ARCAGY/ GINECO GROUP

Phase 3 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡